These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12735887)

  • 21. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy for metabolic syndrome].
    Node K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1737-41. PubMed ID: 17037308
    [No Abstract]   [Full Text] [Related]  

  • 23. 2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.
    Bloomgarden ZT
    Diabetes Care; 2010 Jul; 33(7):e85-9. PubMed ID: 20587709
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiovascular risk associated with the metabolic syndrome.
    Lindsay RS; Howard BV
    Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome and type 2 diabetes: what has gone wrong in type 2 diabetes care?
    Waldhäusl WK
    Curr Diab Rep; 2004 Dec; 4(6):395-6. PubMed ID: 15538999
    [No Abstract]   [Full Text] [Related]  

  • 26. The metabolic syndrome: the emperor needs some consistent clothes.
    Vinicor F; Bowman B
    Diabetes Care; 2004 May; 27(5):1243; author reply 1244. PubMed ID: 15111565
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.
    Meerarani P; Badimon JJ; Zias E; Fuster V; Moreno PR
    Curr Mol Med; 2006 Aug; 6(5):501-14. PubMed ID: 16918371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of syndromes of insulin resistance with coronary artery disease.
    LeWinter MM
    Coron Artery Dis; 2005 Dec; 16(8):477-80. PubMed ID: 16319657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.
    Izzo JL
    J Clin Hypertens (Greenwich); 2003; 5(6 Suppl 4):3-10. PubMed ID: 14688488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to transform a metabolic syndrome score into an insulin sensitivity value?
    Hermans MP; Bouenizabila E; Ahn SA; Rousseau MF
    Diabetes Metab Res Rev; 2016 Jan; 32(1):87-94. PubMed ID: 26111860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin Resistance in Schizophrenia.
    Guest PC
    Adv Exp Med Biol; 2019; 1134():1-16. PubMed ID: 30919329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediators of sympathetic activation in metabolic syndrome obesity.
    Straznicky NE; Eikelis N; Lambert EA; Esler MD
    Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia.
    Osuka A; Matsuoka T; Idoguchi K
    Intern Med; 2009; 48(16):1391-5. PubMed ID: 19687585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
    Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial dysfunction and the metabolic syndrome.
    McVeigh GE; Cohn JN
    Curr Diab Rep; 2003 Feb; 3(1):87-92. PubMed ID: 12643151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.
    Rosenson RS; Reasner CA
    Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
    Ayyobi AF; Brunzell JD
    Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
    Leung PS; de Gasparo M
    J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients?
    Appel SJ
    J Am Acad Nurse Pract; 2005 Aug; 17(8):331-6. PubMed ID: 16045594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.